# COUR Pharma funding: rounds and investors

> COUR Pharma has raised $50M across 1 round since 2026. Investors include Roche Venture Fund, Lumira Ventures and Sanofi. Every round with its source.

Source: https://millionrounds.com/company/cour-pharma (Millionrounds; every figure on the page links to its filing or article)

United States · [Series B startup](https://millionrounds.com/companies)

# Who invested in *COUR Pharma*

One round we have observed, with the 8 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 4 months ago

Follow COUR Pharma and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fcompany%2Fcour-pharma)

Funding summary Updated 27 Oct 2026

**$50M** raised across 1 round since 2026, from 2 sources

- **Latest round:** Series B, $50M Jun 2026
- **Led by:** Roche Venture Fund and Lumira Ventures
- **Investors:** 8 (2 led)

See who backed them

## The rounds

- **Jun 2026** Series B **$50M** [Roche Venture Fund](https://millionrounds.com/fund/roche-venture-fund) Lead [Lumira Ventures](https://millionrounds.com/fund/lumira-ventures) Lead [Sanofi](https://millionrounds.com/fund/sanofi) [Pfizer](https://millionrounds.com/fund/pfizer) [Alpha Wave Global](https://millionrounds.com/fund/alpha-wave-global) [Angelini Ventures](https://millionrounds.com/fund/angelini-ventures) [Alpha Wave Ventures](https://millionrounds.com/fund/alpha-wave-ventures) [T1D Fund: A Breakthrough T1D Venture](https://millionrounds.com/fund/t1d-fund-a-breakthrough-t1d-venture) Reported by Lumira Ventures and 1 other

## Founders and team

From COUR Pharma's own website: 1 founder, 8 on the team.

**John J. Puisis** Founder, Former President and CEO

- **Dannielle Appelhans** President and CEO
- **Brian C. Bock** Chief Financial Officer
- **Sarah Longoria** Chief People Officer
- **Fred Henry** Executive Director, Head of Regulatory Affairs
- **Lori Jester** VP, Technical Operations
- **Noelia Rycerz** VP, Development Operations
- **Robert F. Carey** Lead Independent Director
- **Simon Greenwood** Roche Venture Fund Senior Investment Director

## Everyone who backed them

[Roche Venture Fund](https://millionrounds.com/fund/roche-venture-fund) Corporate VC **1** round, led 1

[Lumira Ventures](https://millionrounds.com/fund/lumira-ventures) VC firm **1** round, led 1

[Sanofi](https://millionrounds.com/fund/sanofi) Investment firm **1** round

[Pfizer](https://millionrounds.com/fund/pfizer) Corporate VC **1** round

[Alpha Wave Global](https://millionrounds.com/fund/alpha-wave-global) Private equity **1** round

[Angelini Ventures](https://millionrounds.com/fund/angelini-ventures) VC firm **1** round

[Alpha Wave Ventures](https://millionrounds.com/fund/alpha-wave-ventures) VC firm **1** round

[T1D Fund: A Breakthrough T1D Venture](https://millionrounds.com/fund/t1d-fund-a-breakthrough-t1d-venture) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=cour-pharma).

## Also claim to have backed them

This firm lists COUR Pharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

[T1D Fund](https://millionrounds.com/fund/t1d-fund) Corporate VC Per its own site

## Quick answers about COUR Pharma

### Who invested in COUR Pharma?

COUR Pharma's investors include Roche Venture Fund, Lumira Ventures, Sanofi, Pfizer and Alpha Wave Global, and 3 more on record. Roche Venture Fund led its latest round.

### How much has COUR Pharma raised?

COUR Pharma has raised $50M across 1 round since 2026.

### When did COUR Pharma last raise?

COUR Pharma's most recent round was a Series B of $50M in Jun 2026, led by Roche Venture Fund.

### What was COUR Pharma's biggest round?

Its most recent round, $50M in Jun 2026, is also its largest on record.

### Who backed COUR Pharma first?

COUR Pharma's first round on record, in Jun 2026, was backed by Roche Venture Fund, Lumira Ventures and Sanofi and 5 others.

### What stage is COUR Pharma at?

COUR Pharma's latest named round is a Series B, in Jun 2026.

### Where is COUR Pharma based?

COUR Pharma is based in the United States.

### Who led COUR Pharma's rounds?

Roche Venture Fund led the Series B in 2026.

## Companies like COUR Pharma

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app